2/4
08:03 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $42.00 price target on the stock.
Medium
Report
Viridian Therapeutics (NASDAQ:VRDN) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $42.00 price target on the stock.
2/4
06:20 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
2/4
06:20 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
2/3
08:48 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
2/3
08:48 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
1/20
10:06 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/20
10:06 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/9
06:10 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Viridian Therapeutics (NASDAQ:VRDN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:34 pm
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
1/7
10:02 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/7
08:23 am
vrdn
Viridian Therapeutics initiated with a Buy at UBS
Low
Report
Viridian Therapeutics initiated with a Buy at UBS
12/23
05:44 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/23
05:44 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/10
08:11 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/10
08:11 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/3
09:19 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/3
09:19 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/3
07:19 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
12/3
07:19 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
12/3
06:19 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:19 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:13 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:13 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair